Molecular Biology Reports

, Volume 34, Issue 1, pp 11–17 | Cite as

Group I intron renders differential susceptibility of Candida albicans to Bleomycin

Original Paper


The alarming increase in drug resistance gained by fungal pathogens has raised an urgent need to develop drugs against novel targets. Candida albicans, an opportunistic fungal pathogen, harbors in its 25S rRNA gene, a self-splicing Group I intron, which can act as a selective drug target. We report that Bleomycin selectively inhibits the self-splicing of Group I intron of C. albicans at IC50 = 1.2 μM, leading to accumulation of precursor RNA as evinced by Reverse Transcriptase PCR. Drug susceptibility assays including MIC determination, growth curve analysis and disc diffusion assays indicate a strong susceptibility of the intron-containing strain (4-1) than the intronless strain (62-1). These results on the preferential targeting of Group I intron of C. albicans by Bleomycin might form a basis for design of small molecules that inhibit self-splicing of RNA as a antimicrobial tool against life-threatening microorganisms.


Group I intron Bleomycin Candida albicans 



We sincerely thank Dr. G. Jayaraman, Dept. of Genetics, University of Madras for his valuable suggestions and for providing gel documentation facilities.


  1. Berry DE, Chang LH, Hecht SM (1985) DNA damage and growth inhibition in cultured human cells by bleomycin congeners. Biochemistry 24:3207–3214PubMedCrossRefGoogle Scholar
  2. Boucher HS, Mercure S, Montplaisir S, Lemay G (1996) A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 180:189–196PubMedCrossRefGoogle Scholar
  3. Carter BJ, De Vroom E, Long CE, Van der Marel G, Van Boom JH., Hecht SM (1990) Site-specific cleavage of RNA by Fe(II) bleomycin. Proc Natl Acad Sci USA 87:9373–9377PubMedCrossRefGoogle Scholar
  4. D’ Andrea AD, Haseltine WA (1978) Modification of DNA by Aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. Proc Natl Acad Sci USA 75:3608–3612PubMedCrossRefGoogle Scholar
  5. Disney MD, Childs JL, Turner DH (2004) New approaches to targeting RNA with oligonucleotides: Inhibition of group I intron self-splicing. Biopolymers 73:151–161PubMedCrossRefGoogle Scholar
  6. Embley TM, Dyal P, Kilvington S (1992) A group I intron in the small subunit ribosomal RNA gene from Naegleria andersoni ssp. andersoni strain PPMF-6. Nucleic Acids Res 20:6411PubMedCrossRefGoogle Scholar
  7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature 391:806–811PubMedCrossRefGoogle Scholar
  8. Gast RJ, Fuerst PA, Byers TJ (1994) Discovery of group I introns in the nuclear small subunit ribosomal RNA genes of Acanthamoeba. Nucleic Acids Res 22:592–596PubMedCrossRefGoogle Scholar
  9. Graybill JR, Bocanegra R, Fothergill A, Rinaldi MG (1996) Bleomycin therapy of experimental disseminated candidiasis in mice. Antimicrob Agents Chemother 40:816–818PubMedGoogle Scholar
  10. Haidle CW, Bearden J Jr (1975) Effect of bleomycin on an RNA–DNA hybrid. Biochem Biophys Res Commun 65:815–821PubMedCrossRefGoogle Scholar
  11. Hecht SM (1986) The chemistry of activated bleomycin. Acc Chem Res 19:383–391CrossRefGoogle Scholar
  12. Krishnamoorthy CR, Vanderwall DE, Kozarich JW, Stubbe J (1988) Chemistry of bleomycin attack on DNA–RNA hybrids and DNAs. J Am Chem Soc 110:2008–2009CrossRefGoogle Scholar
  13. Liu Y, Leibowitz MJ (1993) Variation and in vitro splicing of group I introns in rRNA genes of Pneumocystis carinii. Nucleic Acids Res 21:2415–2421PubMedCrossRefGoogle Scholar
  14. Mehta R, Champney WS (2002) 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob Chemother 46:1546–1549CrossRefGoogle Scholar
  15. Mercure S, Cousineau L, Montplaisir S, Belhumeur P, Lemay G. (1997) Expression of a reporter gene interrupted by the Candida albicans group I intron is inhibited by base analogs. Nucleic Acids Res 25:431–437PubMedCrossRefGoogle Scholar
  16. Mercure S, Montplaisir S, Lemay G (1993) Correlation between the presence of a self-splicing intron in the 25S rDNA of C. albicans and strains susceptibility to 5-fluorocytosine. Nucleic Acids Res 21:6020–6027PubMedCrossRefGoogle Scholar
  17. Miletti KE, Leibowitz MJ (2000) Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition. Antimicrob Agents Chemother 44:958–966PubMedCrossRefGoogle Scholar
  18. Moazed D, Noller HF (1987) Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389–394PubMedCrossRefGoogle Scholar
  19. Ogle JM, Brodersen DE, Clemons WM Jr, Tarry MJ, Carter AP, Ramakrishnan V (2001) Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292:897–902PubMedCrossRefGoogle Scholar
  20. Pearson ND, Prescott CD (1997) RNA as a drug target. Chem Biol 4:409–414PubMedCrossRefGoogle Scholar
  21. Sogin ML, Edman JC (1989) A self-splicing intron in the small subunit rRNA gene of Pneumocystis carinii. Nucleic Acids Res 17:5349–5359PubMedCrossRefGoogle Scholar
  22. Sternberg S (1994) The emerging fungal threat. Science 266:1632–1634PubMedCrossRefGoogle Scholar
  23. Stubbe J, Kozarich JW (1987) Mechanism of bleomycin induced DNA degradation. Chem Rev 87:1107–1136CrossRefGoogle Scholar
  24. Takeshita M, Grollman AP, Ohtsubo E., Ohtsubo H (1978) Interaction of Bleomycin with DNA. Proc Natl Acad Sci USA 75:5983–5987PubMedCrossRefGoogle Scholar
  25. Vicens Q, Westhof E (2001) Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure (Cambridge) 9:647–658CrossRefGoogle Scholar
  26. Von Ahsen U, Davies J, Schroeder R (1991) Antibiotic inhibition of group I ribozyme function. Nature 368:368–370CrossRefGoogle Scholar
  27. Von Ahsen U, Davies J, Schroeder R (1992) Non-competitive inhibition of a group I intron RNA self-splicing by aminoglycoside antibiotics. J Mol Biol 226:935–941CrossRefGoogle Scholar
  28. Von Ahsen U, Schroeder R (1991) Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate. Nucleic Acids Res 19:2261–2265CrossRefGoogle Scholar
  29. Vormann J (2003) Magnesium: nutrition and metabolism. J Mol Aspects Med 24:27–37CrossRefGoogle Scholar
  30. Wank H, Rogers J, Davies J, Schroeder R (1994) Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing. J Mol Biol 236:1001–1010PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Department of Genetics, Dr ALM Post Graduate Institute of Basic Medical SciencesUniversity of MadrasChennaiIndia

Personalised recommendations